NEW YORK (GenomeWeb) – Diagnostics service provider Unilabs will offer Mobidiag's Amplidiag products in Sweden and Norway under a four-year agreement announced today.
The Amplidiag product line covers six diagnostic products for various gastrointestnal infections, including tests for gastroenteritis; carbapenem and vancomycin resistance; and non-invasive Helicobacter pylori testing. The products use well-established qPCR technology, Espoo, Finland-based Mobidiag said.
Unilabs is one of Europe's leading providers of clinical laboratory testing and medical diagnostic imaging services to private and public healthcare providers, local governments, insurance companies, pharmaceutical companies, and the general public. It operates laboratory and medical diagnostic imaging facilities in 12 countries.
"Implementing new multiplex molecular diagnostic tools is a step forward in our efforts to continuously improve our service portfolio and meet customer demands," Helena Enroth, head of R&D in molecular microbiology for Unilabs Sweden, said in a statement. "Mobidiag is able to offer a comprehensive suite for gastrointestinal testing, and importantly, the products meet our expectations for large-scale use."